» Articles » PMID: 32582574

ACE2, Much More Than Just a Receptor for SARS-COV-2

Overview
Date 2020 Jun 26
PMID 32582574
Citations 200
Authors
Affiliations
Soon will be listed here.
Abstract

The rapidly evolving pandemic of severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection worldwide cost many lives. The angiotensin converting enzyme-2 (ACE-2) has been identified as the receptor for the SARS-CoV-2 viral entry. As such, it is now receiving renewed attention as a potential target for anti-viral therapeutics. We review the physiological functions of ACE2 in the cardiovascular system and the lungs, and how the activation of ACE2/MAS/G protein coupled receptor contributes in reducing acute injury and inhibiting fibrogenesis of the lungs and protecting the cardiovascular system. In this perspective, we predominantly focus on the impact of SARS-CoV-2 infection on ACE2 and dysregulation of the protective effect of ACE2/MAS/G protein pathway vs. the deleterious effect of Renin/Angiotensin/Aldosterone. We discuss the potential effect of invasion of SARS-CoV-2 on the function of ACE2 and the loss of the protective effect of the ACE2/MAS pathway in alveolar epithelial cells and how this may amplify systemic deleterious effect of renin-angiotensin aldosterone system (RAS) in the host. Furthermore, we speculate the potential of exploiting the modulation of ACE2/MAS pathway as a natural protection of lung injury by modulation of ACE2/MAS axis or by developing targeted drugs to inhibit proteases required for viral entry.

Citing Articles

Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission.

Al-Momani H, Nelson A, Al Balawi H, Al Balawi D, Aolymat I, Khasawneh A Sci Rep. 2025; 15(1):1811.

PMID: 39805887 PMC: 11730684. DOI: 10.1038/s41598-025-85806-5.


The combined manifestations of dramatically sore throat, congested and edematous mucosa, no-swelling tonsil are specific in acute Omicron pharyngitis.

Zhou L, Zhang L, Xu F BMC Infect Dis. 2025; 25(1):29.

PMID: 39762748 PMC: 11702273. DOI: 10.1186/s12879-024-10364-6.


Antiviral activity of an ACE2-Fc fusion protein against SARS-CoV-2 and its variants.

Bermudez-Abreut E, Fundora-Barrios T, Hernandez Fernandez D, Noa Romero E, Fraga-Quintero A, Casadesus Pazos A PLoS One. 2025; 20(1):e0312402.

PMID: 39752453 PMC: 11698409. DOI: 10.1371/journal.pone.0312402.


Docking heparan sulfate-based ligands as a promising inhibitor for SARS-CoV-2.

Benicio L, Nascimento E, Martins J J Mol Model. 2024; 31(1):19.

PMID: 39666205 DOI: 10.1007/s00894-024-06236-0.


Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition.

Sanchez-Garcia S, Castrillo A, Bosca L, Prieto P Antioxidants (Basel). 2024; 13(11).

PMID: 39594443 PMC: 11591382. DOI: 10.3390/antiox13111301.


References
1.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

2.
Gustafsson F, Holstein-Rathlou N . Angiotensin II modulates conducted vasoconstriction to norepinephrine and local electrical stimulation in rat mesenteric arterioles. Cardiovasc Res. 2000; 44(1):176-84. DOI: 10.1016/s0008-6363(99)00174-1. View

3.
Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S . Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl. 2002; (82):S12-22. DOI: 10.1046/j.1523-1755.62.s82.4.x. View

4.
Nguyen H, Uhal B . The unfolded protein response controls ER stress-induced apoptosis of lung epithelial cells through angiotensin generation. Am J Physiol Lung Cell Mol Physiol. 2016; 311(5):L846-L854. PMC: 5130534. DOI: 10.1152/ajplung.00449.2015. View

5.
Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, Uhal B . Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008; 295(1):L178-85. PMC: 2494775. DOI: 10.1152/ajplung.00009.2008. View